The Texas Children’s Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I - 05/09/11
, LAWRENCE L. GREENHILL, M.D., M. LYNN CRISMON, Pharm.D., ANDREW SEDILLO, M.D., CARYN CARLSON, PH.D., C. KEITH CONNERS, PH.D., JAMES T. McCRACKEN, M.D., JAMES M. SWANSON, PH.D., CARROLL W. HUGHES, PH.D., MARIA E. LLANA, Pharm.D., MOLLY LOPEZ, PH.D., MARCIA G. TOPRAC, PH.D.THE TEXAS CONSENSUS CONFERENCE PANEL ON MEDICATION TREATMENT OF CHILDHOOD ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
ABSTRACT |
Objectives |
Expert consensus methodology was used to develop evidence-based, consensually agreed-upon medication treatment algorithms for attention-deficit/hyperactivity disorder (ADHD) in the public mental health sector. Although treatment algorithms for adult mental disorders have been developed, this represents one of the first attempts to develop similar algorithms for childhood mental disorders. Although these algorithms were developed initially for the public sector, the goals of this approach are to increase the uniformity of treatment and improve the clinical outcomes of children and adolescents with ADHD in a variety of treatment settings.
Method |
A consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence-based consensus algorithms for the pharmacotherapy of childhood ADHD. After a series of presentations of current research evidence and panel discussion, the consensus panel met and drafted the algorithms along with guidelines for implementation.
Results |
The panel developed consensually agreed-upon algorithms for ADHD with and without specific comorbid disorders. The algorithms consist of systematic strategies for psychopharmacological interventions and tactics to ensure successful implementation of the strategies. While the algorithms focused on the medication management of ADHD, the conference emphasized that psychosocial treatments are often a critical component of the overall management of ADHD.
Conclusions |
Medication algorithms for ADHD can be developed with consensus. A companion article will discuss the implementation of these algorithms.
Le texte complet de cet article est disponible en PDF.Key Words : attention-deficit/hyperactivity disorder, algorithm, psychopharmacology, practice parameters
Plan
| Consensus Conference Panel members and their affiliations are listed before the references. This consensus conference was funded by a grant from the Meadows Foundation, Dallas. Members of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder: Caryn Carlson, Ph.D., Department of Psychology, The University of Texas at Austin; C. Keith Conners, Ph.D., Department of Psychiatric and Behavioral Science, Duke University, Durham, NC; M. Lynn Crismon, Pharm.D. (co-chair), College of Pharmacy, The University of Texas at Austin; Lawrence L. Greenhill, M.D., New York State Psychiatric Institute, New York; James T. McCracken, M.D., UCLA Neuropsychiatric Institute, Los Angeles; Robin Moir, M.D., Andrews MHMR Center, Amarillo, TX; William Porcher, M.D., Bluebonnet Trails MHMR Center, Round Rock, TX: Mario Quintanilla, M.D., Nueces County MHMR Center, Corpus Christi, TX; Steven R. Pliszka, M.D. (chair), Department of Psychiatry, University of Texas Health Science Center at San Antonio; Linda Rhodes, M.D., Department of Psychiatry, University of Texas Health Science Center at San Antonio; S. Rogers, family member, Dallas; M. Serna, family member, San Antonio; Cynthia Santos, M.D., Department of Psychiatry, University of Texas Health Science Center at Houston; Beverly Sutton, M.D., Residency Training, Austin State Hospital, Austin, TX; James M. Swanson, Ph.D., Department of Psychiatry, University of California at Irvine; James Terfructe, M.D., private practice and Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas. Members Ex-Officio: Carroll W. Hughes, Ph.D., Psychology Department, Terrell State Hospital, Terrell, TX; Maria E. Llana, Pharm.D., Department of Psychiatry, Scott and White Hospital and Clinic, Temple, TX; Molly Lopez, Ph.D., Texas Department of Mental Health and Mental Retardation, Austin; Nancy MacCabe, Ph.D., Texas Department of Mental Health and Mental Retardation, Austin; Andrew Sedillo, M.D., Texas Department of Mental Health and Mental Retardation, Austin; Sharon Sheldon, Texas Department of Mental Health and Mental Retardation, Austin; Steven P. Shon, M.D., Texas Department of Mental Health and Mental Retardation, Austin; Marcia G. Toprac, Ph.D., Texas Department of Mental Health and Mental Retardation, Austin; Madhukar Trivedi, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas. |
Vol 39 - N° 7
P. 908-919 - juillet 2000 Retour au numéro
Article précédent
- Case Study: Exposure and Response Prevention for an Adolescent With Tourette’s Syndrome and OCD
- DOUGLAS W. WOODS, SHANE S. HOOK, DOUGLAS F. SPELLMAN, PATRICK C. FRIMAN
- The Texas Children’s Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics
- STEVEN R. PLISZKA, LAWRENCE L. GREENHILL, M. LYNN CRISMON, ANDREW SEDILLO, CARYN CARLSON, C. KEITH CONNERS, JAMES T. McCRACKEN, JAMES M. SWANSON, CARROLL W. HUGHES, MARIA E. LLANA, MOLLY LOPEZ, MARCIA G. TOPRAC, THE TEXAS CONSENSUS CONFERENCE PANEL ON MEDICATION TREATMENT OF CHILDHOOD ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?